Autonomic Medicine
Orthostatic Hypotension
Confirm a reproducible orthostatic blood-pressure fall, identify acute volume, medication, cardiac, or neurogenic drivers, and treat disabling cerebral hypoperfusion while avoiding treatment-induced supine hypertension.
Initial Assessment
Confirm orthostatic hypotension and identify immediate hazards
Treat instability or an acute systemic cause before pursuing chronic autonomic phenotyping.
In a patient with syncope, recurrent falls, presyncope, or orthostatic intolerance, first determine whether hypotension is part of an immediately reversible hemodynamic problem. Assess pulse and rhythm, volume status, active bleeding risk, fever or infection, medication exposure, and cardiopulmonary findings; an irregular pulse should prompt caution with automated blood-pressure devices because they can overestimate systolic pressure in atrial fibrillation. BMJBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice
For diagnostic measurement, obtain supine blood pressure after 5 minutes of rest, then measure during standing through 3 minutes. Orthostatic hypotension is a systolic decrease of at least 20 mmHg, at least 30 mmHg in patients with hypertension, and/or a diastolic decrease of at least 10 mmHg within 3 minutes. Document symptoms at each time point because cerebral hypoperfusion symptoms, syncope, and falls determine clinical significance and treatment urgency. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice
If bedside measurements are negative despite a compelling positional history, repeat standardized recordings when symptomatic or use head-up tilt assessment to reproduce the blood-pressure and heart-rate response. A single normal set of orthostatic vital signs should not terminate evaluation when episodes are intermittent, medication-related, or volume sensitive. ccjmccjmEvaluation and management of orthostatic hypotension
Record baseline supine blood pressure and heart rate, standing nadir blood pressure, peak standing heart rate, symptoms, and whether the patient required support or terminated standing. BMJ+2BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best PracticeccjmEvaluation and management of orthostatic hypotension
Use manual confirmation when an arrhythmia is suspected rather than relying solely on an automated device. BMJBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice
Assess fall and syncope consequences promptly; orthostatic hypotension is associated with falls and is an independent mortality marker. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJOrthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ...
| Observed response | Interpretation | Next action |
|---|---|---|
| SBP fall >=20 mmHg, or >=30 mmHg with hypertension, and/or DBP fall >=10 mmHg within 3 minutes | Orthostatic hypotension confirmed. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice | Classify heart-rate response and search for reversible versus neurogenic causes. ccjmccjmEvaluation and management of orthostatic hypotension |
| Orthostatic BP fall with delta HR/delta SBP ratio <0.5 | Supports a neurogenic component; most neurogenic cases have ratio <0.3. ccjmccjmEvaluation and management of orthostatic hypotension | Assess for autonomic failure, peripheral neuropathy, or synucleinopathy and consider formal autonomic evaluation when the cause remains uncertain. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentccjmEvaluation and management of orthostatic hypotension |
| Orthostatic BP fall with delta HR/delta SBP ratio >0.5 | More consistent with intact autonomic compensation and a non-neurogenic contributor, although specificity is imperfect. ccjmccjmEvaluation and management of orthostatic hypotension | Prioritize volume loss, medication effects, and systemic or cardiac causes. BMJ+1BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension |
| HR increase >=30 bpm within 10 minutes of standing or tilt, no orthostatic hypotension, symptoms >=3 months | Meets hemodynamic and duration elements of POTS when alternative causes of sinus tachycardia are excluded. BMJBMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice | Do not treat as orthostatic hypotension; evaluate and manage as POTS. BMJBMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice |
Differential Diagnosis
Use heart-rate compensation to separate reversible from neurogenic hypotension
The standing heart-rate response is a practical discriminator, but medication effects and rhythm disorders can confound it.
A preserved tachycardic response to falling blood pressure favors non-neurogenic orthostatic hypotension. Review for reduced effective circulating volume, acute or chronic blood loss, and drugs that impair volume or vascular compensation; non-neurogenic causes can also substantially worsen pre-existing autonomic failure. BMJ+1BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension The immediate next step is targeted reversal of the identified driver rather than empiric long-term pressor therapy.
A blunted heart-rate response—particularly delta heart rate/delta systolic blood pressure below 0.5—supports impaired baroreflex-mediated autonomic compensation. The ratio had reported sensitivity of 91% and specificity of 88% in one study, but later work found specificity as low as 50%; interpret it with the clinical context rather than as a stand-alone diagnosis. ccjmccjmEvaluation and management of orthostatic hypotension Peripheral neuropathy and synucleinopathies are named neurogenic causes, and coexisting supine hypertension increases the likelihood that management will require a pressor-risk tradeoff. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet
For persistent, unexplained, or progressive suspected neurogenic orthostatic hypotension, escalate phenotyping according to associated neurologic and systemic findings. Available formal evaluations include autonomic nervous system testing, electromyography and nerve-conduction studies, skin biopsy for nerve-fiber density, serum paraneoplastic and autoimmune neuroautoantibody panels, and abdominal fat-pad biopsy. ccjmccjmEvaluation and management of orthostatic hypotension Select these studies to test a specific suspected autonomic neuropathy, paraneoplastic/autoimmune process, or amyloid process rather than ordering a uniform panel.
Interpret a ratio below 0.5 cautiously in patients taking heart-rate-limiting drugs or with a rhythm that prevents an appropriate chronotropic response. ccjmccjmEvaluation and management of orthostatic hypotension
Screen for coexisting supine hypertension before and during therapy because it is common in orthostatic hypotension and may be worsened by treatment. The Lancet+1The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...
When autonomic testing is unavailable, serial standardized orthostatic blood pressure and heart-rate recordings still provide the initial physiologic classification. BMJ+2BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best PracticeccjmEvaluation and management of orthostatic hypotension
Management
Treat functional impairment while minimizing supine hypertension
The treatment target is safer upright function, not normalization of a standing blood-pressure value.
Start by correcting reversible causes and reducing exposures that contribute to orthostatic blood-pressure failure. Recheck supine and standing pressures after each meaningful medication or volume intervention, because treatment response determines whether residual autonomic failure is clinically important. In patients with autonomic failure, non-neurogenic stressors may enhance orthostatic hypotension considerably. BMJBMJAutonomic diseases: clinical features and laboratory evaluation
For severe orthostatic hypotension due to autonomic dysfunction after corrective factors have been excluded and other measures are inadequate, midodrine is a treatment option. BMJBMJMidodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletin Its use requires position-specific blood-pressure surveillance because standard drug treatment can worsen supine hypertension. The Lancet+1The LancetManagement of neurogenic orthostatic hypotension: an updateThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet Avoid evaluating benefit only from an office standing measurement; reassess dizziness, presyncope, falls, and ability to remain upright for required activities.
Droxidopa increases norepinephrine availability and sympathetic tone; fludrocortisone expands volume through sodium and water retention but requires caution for supine hypertension and hypokalemia. Pyridostigmine augments sympathetic ganglionic transmission and may improve standing vascular resistance without significantly affecting supine blood pressure; published reviews describe its benefit as modest. The Lancet+1The LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ... Choice should be driven by the patient’s dominant physiologic deficit and supine blood-pressure liability rather than routine combination treatment.
Before initiating or escalating a pressor strategy, document supine hypertension and establish repeat supine and standing blood-pressure monitoring. The Lancet+1The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...
Monitor for hypokalemia when fludrocortisone is used. NatureNatureDiabetic neuropathy: cutting-edge research and future ...
Consider pyridostigmine when avoidance of worsened supine blood pressure is a dominant management priority, recognizing that improvement may be limited. The Lancet+1The LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ...
Escalate therapy only when symptoms or functional limitation persist after corrective factors are addressed and the expected upright benefit outweighs supine hypertension risk. BMJ+1BMJMidodrine for severe orthostatic hypotension | Drug and Therapeutics BulletinThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet
Supine hypertension changes the treatment threshold
Supine hypertension is common in orthostatic hypotension and can be aggravated by therapies intended to raise standing blood pressure. The Lancet+1The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ... The practical consequence is not to withhold all treatment automatically, but to use symptom burden, fall/syncope risk, upright functional impairment, and paired supine-standing measurements to determine whether the benefit of a pressor regimen justifies its nocturnal or supine blood-pressure risk.
Record supine pressure separately from seated and standing values; a satisfactory standing response does not establish safety if supine pressure rises. The Lancet+1The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...
Reassess the risk-benefit balance after each medication change because both orthostatic symptoms and supine hypertension can change with titration. The Lancet+1The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...
Monitoring
Reassess by posture, symptoms, and cause-specific progression
Monitoring should detect both recurrent upright hypoperfusion and treatment-related supine hypertension.
At follow-up, repeat standardized supine and standing blood pressure and heart rate, record interval syncope, falls, presyncope, and upright activity limitation, and compare findings with the pre-intervention pattern. Orthostatic hypotension is clinically consequential when cerebral hypoperfusion produces symptoms and can lead to syncope and falls. BMJBMJOrthostatic hypotension - Symptoms, diagnosis and treatment Persistent symptoms despite correction of reversible contributors should prompt reassessment for neurogenic disease or an unrecognized systemic cause.
Escalate to formal autonomic and neurologic evaluation when there is a reproducible blunted chronotropic response, progressive symptoms, neuropathic features, or suspicion for synucleinopathy. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentccjmEvaluation and management of orthostatic hypotension Use electromyography/nerve-conduction studies, skin biopsy, antibody testing, or fat-pad biopsy selectively when their result would establish a treatable or prognostically important etiology. ccjmccjmEvaluation and management of orthostatic hypotension
Do not make treatment decisions from a single blood-pressure domain. Pressor therapy may improve standing blood pressure while worsening supine hypertension, and the evidence base for many interventions remains heterogeneous with inconsistent symptom and postural-blood-pressure outcomes. The Lancet+2The LancetManagement of neurogenic orthostatic hypotension: an updateThe LancetDiagnosis and treatment of orthostatic hypotension - The LancetWolters KluwerEfficacy of treatments for orthostatic hypotension : Age and Ageing For refractory cases, define success as improved safety and function with an acceptable supine blood-pressure tradeoff.
Repeat orthostatic measurements after correcting a suspected reversible factor or changing a medication regimen. BMJ+1BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension
Track falls and syncope explicitly rather than relying on dizziness alone. BMJ+1BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJOrthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ...
Re-evaluate for POTS only when tachycardia occurs without orthostatic hypotension and the chronicity criteria are met. BMJBMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice
References
- Orthostatic hypotension - Symptoms, diagnosis and treatment — bestpractice.bmj.com · bestpractice.bmj.com
- Assessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice — bestpractice.bmj.com · bestpractice.bmj.com
- Postural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice — bestpractice.bmj.com · bestpractice.bmj.com
- Midodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletin — dtb.bmj.com · dtb.bmj.com
- Effects of intensive blood pressure treatment on orthostatic ... — www.bmj.com · www.bmj.com
- Autonomic diseases: clinical features and laboratory evaluation — jnnp.bmj.com · jnnp.bmj.com
- Orthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ... — bestpractice.bmj.com · bestpractice.bmj.com
- Management of neurogenic orthostatic hypotension: an update — www.thelancet.com · www.thelancet.com
- Diagnosis and treatment of orthostatic hypotension - The Lancet — www.thelancet.com · www.thelancet.com
- Orthostatic Hypotension: a clinical marker for the body-first subtype of patients with Parkinson’s Disease | npj Parkinson's Disease — www.nature.com · www.nature.com
- Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension | Hypertension Research — www.nature.com · www.nature.com
- Orthostatic hypotension without co-existent supine hypertension is associated with impaired cerebral oxygenation: findings from the Irish Longitudinal Study on Ageing (TILDA) | Journal of Human Hypertension — www.nature.com · www.nature.com
- Diabetic neuropathy: cutting-edge research and future ... — www.nature.com · www.nature.com
- Efficacy of treatments for orthostatic hypotension : Age and Ageing — journals.lww.com · journals.lww.com
- Review of management strategies for orthostatic hypotension in ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Orthostatic Hypotension Associated With Baroreceptor Dysfunction ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Characteristics, Management, and Outcomes of Hospitalized ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Measurement and management of adult blood pressure in the peri ... — associationofanaesthetists-publications.onlinelibrary.wiley.com · associationofanaesthetists-publications.onlinelibrary.wiley.com
- Postural orthostatic tachycardia syndrome: clinical presentation ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Pyridostigmine for the Management of Neurogenic Orthostatic ... — journals.lww.com · journals.lww.com
- Treatment of autonomic dysfunction in Parkinson disease and ... — movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
- Approach to Cardiovascular Autonomic Dysfunction in Patients with ... — movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
- Orthostatic hypotension and cognitive impairment in ... — movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
- Evaluation and management of orthostatic hypotension — www.ccjm.org · www.ccjm.org